Thoughts on the public biotech bust (and does it matter for startups?)

Disclaimer: THIS POST IS NOT FINANCIAL OR INVESTING ADVICE. If you’re looking for that, consult with someone working as a financial advisor and/or (maybe not) the Twitter/Reddit stonk memes. Public biotech valuations have collapsed, plummeting far beyond the overall market. Much has been written about public biotech bust (here, here, here, and Google if youContinue reading “Thoughts on the public biotech bust (and does it matter for startups?)”